274 related articles for article (PubMed ID: 34413861)
21. A Novel Signature Based on m
Liu D; Li B; Yang M; Xing Y; Liu Y; Yuan M; Liu F; Wu Y; Ma X; Jia Y; Wang Y; Ji M; Zhu J
Adv Biol (Weinh); 2024 Apr; 8(4):e2300534. PubMed ID: 38314942
[TBL] [Abstract][Full Text] [Related]
22. Nomograms integrating the collagen signature and systemic immune-inflammation index for predicting prognosis in rectal cancer patients.
Yu X; Jiang W; Dong X; Yan B; Xu S; Lin Z; Zhuo S; Yan J
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38513282
[TBL] [Abstract][Full Text] [Related]
23. Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker.
Wang S; Huang X; Zhao S; Lv J; Li Y; Wang S; Guo J; Wang Y; Wang R; Zhang M; Qiu W
Front Immunol; 2024; 15():1327565. PubMed ID: 38357546
[TBL] [Abstract][Full Text] [Related]
24. Extracellular cancer‑associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor‑promoting roles and prognosis biomarker functions.
Wang Y; Xu M; Yao Y; Li Y; Zhang S; Fu Y; Wang X
Oncol Lett; 2024 Apr; 27(4):167. PubMed ID: 38449793
[TBL] [Abstract][Full Text] [Related]
25. Establishment and Validation of Lactate Metabolism-Related Genes as a Prognostic Model for Gastric Cancer.
Hu J; Xu Q; Fei Y; Tan Z; Pan L
Curr Mol Med; 2024 May; ():. PubMed ID: 38726778
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the immunogenic cell death pathways in gastric adenocarcinoma: A multi-omics study.
Gu R; Chen Z; Dong M; Li Z; Wang M; Liu H; Shen X; Huang Y; Feng J; Mei K
Environ Toxicol; 2024 May; ():. PubMed ID: 38717048
[TBL] [Abstract][Full Text] [Related]
27. A degradome-related signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma based on machine learning procedure.
Deng Z; Feng Q; Zhao D; Huang Z
Medicine (Baltimore); 2024 Apr; 103(15):e37728. PubMed ID: 38608069
[TBL] [Abstract][Full Text] [Related]
28. Identifying prognostic signature in ovarian cancer using DirGenerank.
Wang JY; Chen LL; Zhou XH
Oncotarget; 2017 Jul; 8(28):46398-46413. PubMed ID: 28615526
[TBL] [Abstract][Full Text] [Related]
29. Extracellular Matrix-Associated Pathways Promote the Progression of Gastric Cancer by Impacting the Dendritic Cell Axis.
Wang Z; Wang Z; Hu X; Han Q; Chen K; Pang G
Int J Gen Med; 2021; 14():6725-6739. PubMed ID: 34675633
[TBL] [Abstract][Full Text] [Related]
30. Deep learning-based clustering robustly identified two classes of sepsis with both prognostic and predictive values.
Zhang Z; Pan Q; Ge H; Xing L; Hong Y; Chen P
EBioMedicine; 2020 Dec; 62():103081. PubMed ID: 33181462
[TBL] [Abstract][Full Text] [Related]
31. An integrated signature of clinical metrics and immune-related genes as a prognostic indicator for ST-segment elevation myocardial infarction patient survival.
Gao W; Wang XY; Wang XJ; Huang L
Heliyon; 2024 May; 10(10):e31247. PubMed ID: 38813183
[TBL] [Abstract][Full Text] [Related]
32. Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis.
Zhao K; Li Z; Li Y; Yao S; Huang Y; Wang Y; Zhang F; Wu L; Chen X; Liang C; Liu Z
Oncoimmunology; 2020 Oct; 9(1):1841935. PubMed ID: 33194320
[TBL] [Abstract][Full Text] [Related]
33. Identification of A unique stress response state of T cells-related gene signature in patients with gastric cancer.
Yang Q; Li X; Zhu W
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38848147
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel gene signature related to prognosis and metastasis in gastric cancer.
Elizazu J; Artetxe-Zurutuza A; Otaegi-Ugartemendia M; Moncho-Amor V; Moreno-Valladares M; Matheu A; Carrasco-Garcia E
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38480611
[TBL] [Abstract][Full Text] [Related]
35. Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes.
Min L; Zhao Y; Zhu S; Qiu X; Cheng R; Xing J; Shao L; Guo S; Zhang S
Transl Oncol; 2017 Feb; 10(1):99-107. PubMed ID: 28013168
[TBL] [Abstract][Full Text] [Related]
36. Construction of gastric cancer prognostic signature based on the E26 transcription factor and the identification of novel oncogene ELK3.
Liu C; Zhou L; Chen Z
Am J Cancer Res; 2024; 14(4):1831-1849. PubMed ID: 38726274
[TBL] [Abstract][Full Text] [Related]
37. Network-based biomarkers enhance classical approaches to prognostic gene expression signatures.
Barter RL; Schramm SJ; Mann GJ; Yang YH
BMC Syst Biol; 2014; 8 Suppl 4(Suppl 4):S5. PubMed ID: 25521200
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer.
Sun Z; Zhang T; Ahmad MU; Zhou Z; Qiu L; Zhou K; Xiong W; Xie J; Zhang Z; Chen C; Yuan Q; Chen Y; Feng W; Xu Y; Yu L; Wang W; Yu J; Li G; Jiang Y
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38271117
[TBL] [Abstract][Full Text] [Related]
39. Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms.
Liu X; Wang W; Zhang X; Liang J; Feng D; Li Y; Xue M; Ling B
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102155. PubMed ID: 38495844
[TBL] [Abstract][Full Text] [Related]
40. A new molecular signature method for prediction of driver cancer pathways from transcriptional data.
Rykunov D; Beckmann ND; Li H; Uzilov A; Schadt EE; Reva B
Nucleic Acids Res; 2016 Jun; 44(11):e110. PubMed ID: 27098033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
